Implementation of new Vaccine production unit in an existing facility. Increase of capacity from 34 to 56 million doses.
Implementation of new Green Field Viral Vector Production facility, including 2 cGMP production units.
Implementation of new High Potent Drug Product Manufacturing unit in an existing facility.
Transformation of a decontamination station from batch to continuous decontamination.
Development and qualification of Site Data Integrity compliance program and corrective action management.
Development of Global Validation Strategy and deployment for serialization packaging systems (IT and equipment systems).
Implementation of new Green Field Aseptic Fill & Finish /QC Lab facility (1800m²), dedicated to the aseptic filling of a wide range of biological products.
Implementation of new Aseptic Vials Filling Line in a new Filling area as part of an extension of the current production building.